Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing

Gain insights into the latest advances in NTRK fusion testing and recent advances in tumor-agnostic TRK inhibition through expert-guided discussion.

Share

Program Content

Activities

TRK Inhibitors
Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2020

Expires: August 20, 2021

Activities

TRK Inhibitors: FAQ
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 14, 2020

Expires: August 13, 2021

Activities

<i>NTRK</i> Testing
Rationale for Targeting TRK Fusions in Solid Tumors and Implementing NTRK Testing in the Clinic
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

Using TRK Inhibitors
Clinical Data and Current Indications for TRK Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

TRKi Resistance/Safety
TRK Inhibitor Resistance and Safety
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

Activities

Using TRK Inhibitors
How I Use TRK Inhibitors in Patients With NTRK Fusion–Positive Tumors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Genentech TEXT Only